Literature DB >> 6172023

Studies of CSF 5-HIAA in depression and suicidal behaviour.

M Asberg, L Träskman.   

Abstract

The present series of studies of CSF monoamine metabolites support the hypothesis of a role for serotonin in depressive illness, insofar that depressed patients have slightly lower CSF 5-HIAA concentrations than normal controls. Apparently a normal association between CSF 5-HIAA and platelet MAO activity is disrupted in depression. The importance of serotonin does not, however, appear to be confined to depressive illness. There is a strong association between a low CSF 5-HIAA and a tendency to suicidal behaviour, also outside the setting of depression. The nature of this relationship is unclear, but it is suggested that certain personality features may form a mediating link. A connection between a low serotonin turnover and a weakened control of aggressive or hostile impulses is one possibility.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172023     DOI: 10.1007/978-1-4684-3860-4_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Inferring candidate genes for attention deficit hyperactivity disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS).

Authors:  M Reuter; P Kirsch; J Hennig
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 site.

Authors:  Brice Le François; Jeremy Soo; Anne M Millar; Mireille Daigle; Anne-Marie Le Guisquet; Samuel Leman; Frédéric Minier; Catherine Belzung; Paul R Albert
Journal:  Neurobiol Dis       Date:  2015-07-15       Impact factor: 5.996

3.  "Out, out, brief candle! Life's but a walking shadow": 5-HTTLPR Is Associated With Current Suicidal Ideation but Not With Previous Suicide Attempts and Interacts With Recent Relationship Problems.

Authors:  Janos Bokor; Sandor Krause; Dora Torok; Nora Eszlari; Sara Sutori; Zsofia Gal; Peter Petschner; Ian M Anderson; Bill Deakin; Gyorgy Bagdy; Gabriella Juhasz; Xenia Gonda
Journal:  Front Psychiatry       Date:  2020-06-25       Impact factor: 4.157

Review 4.  Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches.

Authors:  Rayan K Al Jurdi; Alan Swann; Sanjay J Mathew
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

5.  Connecting inflammation with glutamate agonism in suicidality.

Authors:  Sophie Erhardt; Chai K Lim; Klas R Linderholm; Shorena Janelidze; Daniel Lindqvist; Martin Samuelsson; Kristina Lundberg; Teodor T Postolache; Lil Träskman-Bendz; Gilles J Guillemin; Lena Brundin
Journal:  Neuropsychopharmacology       Date:  2012-12-03       Impact factor: 7.853

6.  Prenatal SAMe Treatment Induces Changes in Brain Monoamines and in the Expression of Genes Related to Monoamine Metabolism in a Mouse Model of Social Hierarchy and Depression, Probably via an Epigenetic Mechanism.

Authors:  Maria Becker; Karin Abaev; Elena Shmerkin; Liza Weinstein-Fudim; Albert Pinhasov; Asher Ornoy
Journal:  Int J Mol Sci       Date:  2022-10-07       Impact factor: 6.208

7.  Genetic and familial environmental effects on suicide--an adoption study of siblings.

Authors:  Liselotte Petersen; Thorkild I A Sørensen; Per Kragh Andersen; Preben Bo Mortensen; Keith Hawton
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.